Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
418 B cell regulation of anti-PD-1 immune checkpoint inhibition
- 1University of Arkansas for Medical Sciences, Little Rock, AR, USA
Related
- Amygdala metabolic activity on FDG PET is associated with survival, response to immune checkpoint inhibition, and tumor immune signaling in non-small cell lung cancer
- Tumour-derived factors prime microglia for immune checkpoint-mediated T-cell regulation
- Health-related quality of life with adjuvant immune checkpoint inhibition in renal cell carcinoma: A qualitative study of UK participants in the phase III RAMPART trial
- Moving Beyond the Plateau in Immune Checkpoint Inhibition-The Imperative of Early Referral and Precision Strategies.
- Tarloxotinib targets tumor hypoxia to improve therapeutic efficacy of immune checkpoint inhibition in a MyD88-dependent manner.
BibTeX
@article{cannon2026cell,
title = {{418 B cell regulation of anti-PD-1 immune checkpoint inhibition}},
author = {Martin J Cannon and Richard A Connor and Lisa R Williams},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0418},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0418},
note = {CC BY},
}
RIS
TY - JOUR
TI - 418 B cell regulation of anti-PD-1 immune checkpoint inhibition
AU - Martin J Cannon
AU - Richard A Connor
AU - Lisa R Williams
PY - 2026
DA - 2026/11/06
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0418
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0418
SN - 2051-1426
ER -